Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis.

Reggy, A A

Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis. [electronic resource] - Journal of the National Cancer Institute Nov 1997 - 1566-7 p. digital

Publication Type: Comment; Editorial

0027-8874

10.1093/jnci/89.21.1566 doi


Animals
Anti-HIV Agents--administration & dosage
Carcinogens--administration & dosage
Female
HIV Infections--prevention & control
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical--prevention & control
Mice
National Institutes of Health (U.S.)
Placenta
Pregnancy
Pregnancy Complications, Infectious
Risk
United States
Zidovudine--administration & dosage